73 related articles for article (PubMed ID: 6007014)
1. [Autoimmunity of cancer in tumor-bearing bodies and HML (high-medium-low) classification].
Takeda K; Kikuchi U; Yamawaki S; Aizawa M; Nakamura K
Nihon Rinsho; 1966 Feb; 24(2):346-57. PubMed ID: 6007014
[No Abstract] [Full Text] [Related]
2. Inhibitory effect of isologous regional lymphnode cells from the methylcholanthrene-induced sarcoma bearing mice on the tumor in vivo.
Kashihara E
Acta Med Okayama (1952); 1970 Apr; 24(2):161-73. PubMed ID: 4247892
[No Abstract] [Full Text] [Related]
3. [Effects of aprotinin on the grafting of methylcholanthrene-induced sarcoma in rats].
Laurentaci G; Dioguardi D; Pascone M
Arch Sci Med (Torino); 1977; 134(3):283-92. PubMed ID: 304713
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmunity of experimental animals with induced carcinoma. 1. Autotransplantability of rats with methylcholanthrene-induced sarcoma].
Takeda K; Aizawa M; Tsuji Y; Yamawaki S; Nakamura K
Saishin Igaku; 1965 Oct; 20(10):2826-35. PubMed ID: 5886833
[No Abstract] [Full Text] [Related]
5. Influence of BCG infection on growth of 3-methylcholanthrene-induced rat sarcomas.
Baldwin RW; Pimm MV
Rev Eur Etud Clin Biol; 1971 Nov; 16(9):875-81. PubMed ID: 4945964
[No Abstract] [Full Text] [Related]
6. In vitro studies on the inhibitory effect of lymph-node cells. I. Antitumor activity of regional lymph-node cells from methylcholanthrene-induced sarcoma bearing mice on the same primary culture sarcoma cells.
Osugi M
Acta Med Okayama (1952); 1970 Aug; 24(4):447-56. PubMed ID: 4254199
[No Abstract] [Full Text] [Related]
7. Studies on transplantation immunity of methylcholanthrene-induced tumor by use of transplantation in lymph nodes and of diffusion chamber.
Kitano M; Okada Y; Nagaishi C
Exp Med Surg; 1969; 27(4):357-83. PubMed ID: 5384538
[No Abstract] [Full Text] [Related]
8. Simultaneous decrease of tumor-specific antigenicity and "hybrid effect" in a murine methylcholanthrene-induced sarcoma.
Oth D; Donner M; Burg C
Transplantation; 1969 Nov; 8(5):742-5. PubMed ID: 5403331
[No Abstract] [Full Text] [Related]
9. [Degranulation of the mast cells of syngeneic rats induced with sera of rats treated with grafts of methylcholanthrene-induced sarcoma].
Laurentaci G; Chincoli S; Traficante A
Minerva Chir; 1978 Oct; 33(19):1275-84. PubMed ID: 692910
[TBL] [Abstract][Full Text] [Related]
10. [Spontaneous metastasising of a methylcholanthrene induced sarcoma in animals with intact respective reduced immune reactivity].
Boeryd B; Hagmar B; Suurküla M
Nord Med; 1970 Nov; 84(45):1440. PubMed ID: 5481053
[No Abstract] [Full Text] [Related]
11. Common transplantation antigens on methylcholanthrene-induced murine sarcomas detected by three assays of tumor rejection.
Leffell MS; Coggin JH
Cancer Res; 1977 Nov; 37(11):4112-9. PubMed ID: 908044
[No Abstract] [Full Text] [Related]
12. [Antibodies against cells of methylcholanthrene sarcoma in the blood of intact mice].
Fedorovskaia MI; Vetrova EP; Umanskii IuA
Biull Eksp Biol Med; 1973 Jul; 76(7):78-80. PubMed ID: 4774443
[No Abstract] [Full Text] [Related]
13. Inhibition of metastasis in rats immunized with xenogenized autologous tumor cells after excision of the primary tumor.
Kobayashi H; Gotohda E; Hosokawa M; Kodama T
J Natl Cancer Inst; 1975 Apr; 54(4):997-9. PubMed ID: 1127731
[TBL] [Abstract][Full Text] [Related]
14. Tumor autoimmunity against methylcholanthrene-induced sarcomas of the rat.
Takeda K; Aizawa M; Kikuchi Y; Yamawaki S; Nakamura K
Gan; 1966 Jun; 57(3):221-40. PubMed ID: 5962636
[No Abstract] [Full Text] [Related]
15. Syngeneic monoclonal antibodies to a methylcholanthrene-induced mouse sarcoma.
Lennox E; Cohn J; Lowe T
Transplant Proc; 1980 Mar; 12(1):95-8. PubMed ID: 7368297
[No Abstract] [Full Text] [Related]
16. Immune status of the primary host toward its own methylcholanthrene-induced sarcomas.
Stjernswärd J
J Natl Cancer Inst; 1968 Jan; 40(1):13-22. PubMed ID: 5635014
[No Abstract] [Full Text] [Related]
17. Recombinant tumor necrosis factor alpha inhibits growth of methylcholanthrene-induced sarcoma and enhances natural killer activity of tumor-infiltrating lymphocytes in aging rats.
Ziółkowska M; Nowak JJ; Janiak M; Ryzewska A
Arch Immunol Ther Exp (Warsz); 1993; 41(5-6):357-64. PubMed ID: 8010877
[TBL] [Abstract][Full Text] [Related]
18. Distribution of radiolabeled alloantibodies in mice bearing 3-methylcholanthrene-induced sarcoma.
Buchsbaum DJ; Walker PC; Johnson EA
Cancer Res; 1979 Sep; 39(9):3363-8. PubMed ID: 476667
[TBL] [Abstract][Full Text] [Related]
19. [Heterogeneity of murine sarcoma cells for transplantability due to their different susceptibilities to the lytic action of macrophages].
Ustinov AS; Lavrovskiĭ VA
Biull Eksp Biol Med; 1988 Mar; 105(3):322-4. PubMed ID: 3349171
[TBL] [Abstract][Full Text] [Related]
20. Morphologic studies of lymphoid tissues during the growth of an isotransplanted mouse tumor.
Krüger G
J Natl Cancer Inst; 1967 Jul; 39(1):1-15. PubMed ID: 6028286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
